Renal denervation: one step backwards, three steps forward

Markus P. Schlaich; George L. Bakris

doi:10.1038/s41581-018-0040-4

Renal denervation: one step backwards, three steps forward

Markus P. Schlaich
, George L. Bakris

UWA Medical School

Research output: Contribution to journal › Editorial › peer-review

6 Citations (Web of Science)

Abstract

Many considered the failure of the SYMPLICITY HTN-3 trial to represent the end of therapeutic renal denervation. However, promising preliminary data from the SPYRAL HTN-OFF MED study and more recently the SPYRAL HTN-ON MED and RADIANCE-HTN SOLO studies support the efficacy of this intervention for blood pressure lowering in patients with hypertension.

Original language	English
Pages (from-to)	602-604
Number of pages	3
Journal	Nature Reviews Nephrology
Volume	14
Issue number	10
DOIs	https://doi.org/10.1038/s41581-018-0040-4
Publication status	Published - Oct 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41581-018-0040-4

Cite this

@article{806587c0c5364533bfae96933395a3b2,

title = "Renal denervation: one step backwards, three steps forward",

abstract = "Many considered the failure of the SYMPLICITY HTN-3 trial to represent the end of therapeutic renal denervation. However, promising preliminary data from the SPYRAL HTN-OFF MED study and more recently the SPYRAL HTN-ON MED and RADIANCE-HTN SOLO studies support the efficacy of this intervention for blood pressure lowering in patients with hypertension.",

author = "Schlaich, \{Markus P.\} and Bakris, \{George L.\}",

year = "2018",

month = oct,

doi = "10.1038/s41581-018-0040-4",

language = "English",

volume = "14",

pages = "602--604",

journal = "Nature Reviews Nephrology",

issn = "1759-5061",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - Renal denervation

T2 - one step backwards, three steps forward

AU - Schlaich, Markus P.

AU - Bakris, George L.

PY - 2018/10

Y1 - 2018/10

N2 - Many considered the failure of the SYMPLICITY HTN-3 trial to represent the end of therapeutic renal denervation. However, promising preliminary data from the SPYRAL HTN-OFF MED study and more recently the SPYRAL HTN-ON MED and RADIANCE-HTN SOLO studies support the efficacy of this intervention for blood pressure lowering in patients with hypertension.

AB - Many considered the failure of the SYMPLICITY HTN-3 trial to represent the end of therapeutic renal denervation. However, promising preliminary data from the SPYRAL HTN-OFF MED study and more recently the SPYRAL HTN-ON MED and RADIANCE-HTN SOLO studies support the efficacy of this intervention for blood pressure lowering in patients with hypertension.

UR - https://www.scopus.com/pages/publications/85049568219

U2 - 10.1038/s41581-018-0040-4

DO - 10.1038/s41581-018-0040-4

M3 - Editorial

C2 - 29980772

AN - SCOPUS:85049568219

SN - 1759-5061

VL - 14

SP - 602

EP - 604

JO - Nature Reviews Nephrology

JF - Nature Reviews Nephrology

IS - 10

ER -

Renal denervation: one step backwards, three steps forward

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this